Pierre Blanchard, Radiation Oncology Clinical Section Chief at Gustave Roussy Cancer Institute, posted on X:
“V04 randomized study on Gem/Cis chemoradiation for bladder cancer presented by Morgan Michalet.
Surprising lower survival (NS but small cohort) that may be a cause of concern. Related to higher metastases in Gem/Cis group.”
ESTRO 2025 Live Updates on OncoDaily.
